Targeting glucose in acute myocardial infarction: Has glucose, insulin, and potassium infusion missed the target?

Diabetes Care

Volumn 30, Issue 12, 2007, Pages 3026-3028

  Chaudhuri, Ajay ^a   Miller, Michael ^b   Nesto, Richard ^c   Rosenberg, Noah ^b   Dandona, Paresh ^a,d,e  

^a UNIVERSITY AT BUFFALO   (United States)

^b SANOFI   (France)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Diabetes Endocrinology Center of WNY   (United States)

^e Diabetes Endocrinology Center of Western New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; POTASSIUM;

ACUTE HEART INFARCTION; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HEART INFARCTION SIZE; HUMAN; HYPERGLYCEMIA; MORTALITY;

BLOOD GLUCOSE; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; MYOCARDIAL INFARCTION; POTASSIUM; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS;

EID: 37149029743     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-1220     Document Type: Article

References (18)

1. The ACE/ADA Task Force on Inpatient Diabetes: American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control: a call to action. Diabetes Care 29:1955-1962, 2006
2. Dandona P, Mohanty P, Chaudhuri A, Garg R, Aljada A: Insulin infusion in acute illness. J Clin Invest 115:2069-2072, 2005
3. Vanhorebeek I, Langouche L, Van den Berghe G: Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness? Curr Opin Crit Care 11:304-311, 2005
4. Chaudhuri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopadhyay A, Calieri J, Hoffmeyer D, Tufail S, Ghanim H, Aljada A, Dandona P: Anti-inflammatory and pro-fibrinolytic effect of insulin in acute ST-elevation myocardial infarction. Circulation 109:849-854, 2004
5. Visser L, Zuurbier CJ, Hoek FJ, Opmeer BC, de Jonge E, de Mol BA, van Wezel HB: Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. Br J Anaesth 95:448-457, 2005
6. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S: Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 86:3257-3265, 2001
7. Libby P, Simon DI: Inflammation and thrombosis: the clot thickens. Circulation 103:1718-1720, 2001
8. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126, 1999
9. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L: Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: CREATE-ECLA randomized controlled trial. JAMA 293:437-446, 2005
10. Rackley CE, Russell RO Jr, Rogers WJ, Mantle JA, McDaniel HG, Papapietro SE: Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction. Am Heart J 102:1038-1049, 1981
11. Yusuf S, Mehta SR, Diaz R, Paolasso E, Pais P, Xavier D, Xie C, Ahmed RJ, Khazmi K, Zhu J, Liu L: Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction. Am Heart J 148:1068-1078, 2004
12. Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, Theroux P, Oliveira GB, Todaro TG, Mojcik CF, Armstrong PW, Granger CB: Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 27:1289-1297, 2006
13. Cheung NW, Wong VW, McLean M: The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) Study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 29:765-770, 2006
14. van der Horst IC, Nijsten MW, Vogelzang M, Zijlstra F: Persistent hyperglycemia is an independent predictor of outcome in acute myocardial infarction (Letter). Cardiovasc Diabetol 6:2, 2007
15. Diaz R: Glucose-insulin-potassium in STEMI patients: results of OASIS-6 study and a combined analysis with CREATE ECLA trial. Paper presented at the European Society of Cardiology Scientific Congress, 3 September 2006, Fira Gran Via M2, Barcelona, Spain
16. Zhang HX, Zang YM, Huo JH, Liang SJ, Zhang HF, Wang YM, Fan Q, Guo WY, Wang HC, Gao F: Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs. J Cardiovasc Pharmacol 48:306-313, 2006
17. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067-2072, 2002
18. Srinivasan M, Herrero P, McGill JB, Bennik J, Heere B, Lesniak D, Davila-Roman VG, Gropler RJ: The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus. J Am Coll Cardiol 46:42-48, 2005